NanoBioFAB Secures $1.1M DHA SBIR Phase II contract for Revolutionary AI-Driven Nanosensor Technology in Pathogen Detection and Wound Infection Prediction Device
Frederick, MD (PRWEB) July 13, 2023 -- NanoBioFAB, an innovative medical device company with advanced AI-driven nanosensor technology, is pleased to announce the receipt of a $1.1 million Defence Health Agency (DHA) SBIR Phase II contract for the research and development of the groundbreaking medical device designed for pathogen identification and wound infection prediction.
The cutting-edge technology represents a significant paradigm shift in the early detection and prediction of pathogens associated with wound infections. This revolutionary wearable device utilizes a compact nanosensor array and state-of-the-art artificial intelligence algorithms to continuously monitor the release of microbial gases from pathogens on the surface of wound infections. By providing real-time detection, prediction, and differentiation of bacterial and fungal pathogens, this device sets new standards for accuracy and reliability in wound infection monitoring.
"As a woman and minority-owned company, NanoBioFAB is dedicated to enhancing patient outcomes and reducing healthcare costs through the utilization of advanced AI and nanosensor technology," stated Xiaonao Liu, PhD, Founder and CEO of NanoBioFAB. "Functioning as a proactive smoke detector for infections, this device enables healthcare providers to take prompt action. Its intuitive design and user-friendly interface empower patients to actively participate in their own care and recovery, making it a valuable asset in both civilian and military healthcare settings."
Under the leadership of CEO Kathie Callahan Brady, FITCI, one of Maryland's largest business incubators and accelerators, is proud to support NanoBioFAB's remarkable progress. "Since joining FITCI in 2018, NanoBioFAB has achieved tremendous growth in just a few short years," said Callahan Brady. "We are thrilled to be a part of their exciting journey and to contribute to their ongoing success."
Headquartered in the Frederick Innovative Technology Center, Inc. (FITCI) in Frederick County, Maryland, NanoBioFAB benefits from its strategic location. With ample funding and resources, NanoBioFAB is excellently positioned to deliver revolutionary solutions that will transform the field of wound care.
Company descriptions
NanoBioFAB is a leading innovator in medical device technology, focusing on wearable, intelligent, and affordable healthcare solutions. Our advanced AI-driven nanosensor technology enables real-time, accurate, user-friendly, and accessible features in our solutions. Based at Maryland's Frederick Innovative Technology Center, Inc. (FITCI), NanoBioFAB is dedicated to delivering cutting-edge solutions that revolutionize pathogen identification, early infection detection, and enhance patient care while optimizing cost savings. Discover our innovative offerings at http://www.nanobiofab.com.
Frederick Innovative Technology Center, Inc. FITCI fosters entrepreneurial activity at the very root of Frederick’s science and technology industries. Its mission is to encourage innovation and accelerate development of commercially viable businesses through coaching, connections and equitable access to resources within a nurturing environment. FITCI broadens economic growth by supporting early-stage life science, IT, Agtech, renewable energy and related start-up companies with tailored amenities such as office and wet lab space, business services, and strategic support for emerging entrepreneurs.
Dr. Xiaonao Liu, Founder, NanoBioFAB, http://www.nanobiofab.com, 805-452-6498, [email protected]
Share this article